Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

SF 3027

as introduced - 91st Legislature (2019 - 2020) Posted on 02/13/2020 02:55pm

KEY: stricken = removed, old language.
underscored = added, new language.

Current Version - as introduced

Line numbers 1.1 1.2 1.3 1.4 1.5
1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 1.22 2.1 2.2 2.3 2.4

A bill for an act
relating to health; allowing patients who receive disability payments from the
Railroad Retirement Board to pay a lower enrollment fee for the medical cannabis
program; amending Minnesota Statutes 2018, section 152.35.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

Minnesota Statutes 2018, section 152.35, is amended to read:


152.35 FEES; DEPOSIT OF REVENUE.

(a) The commissioner shall collect an enrollment fee of $200 from patients enrolled
under this section. If the patient attests to receiving new text begindisability payments from the Railroad
Retirement Board,
new text endSocial Security disability, new text beginor new text endSupplemental Security Insurance payments,
or new text beginto new text endbeing enrolled in medical assistance or MinnesotaCare, then the fee shall be $50. The
fees shall be payable annually and are due on the anniversary date of the patient's enrollment.
The fee amount shall be deposited in the state treasury and credited to the state government
special revenue fund.

(b) The commissioner shall collect an application fee of $20,000 from each entity
submitting an application for registration as a medical cannabis manufacturer. Revenue
from the fee shall be deposited in the state treasury and credited to the state government
special revenue fund.

(c) The commissioner shall establish and collect an annual fee from a medical cannabis
manufacturer equal to the cost of regulating and inspecting the manufacturer in that year.
Revenue from the fee amount shall be deposited in the state treasury and credited to the
state government special revenue fund.

(d) A medical cannabis manufacturer may charge patients enrolled in the registry program
a reasonable fee for costs associated with the operations of the manufacturer. The
manufacturer may establish a sliding scale of patient fees based upon a patient's household
income and may accept private donations to reduce patient fees.